Insmed (INSM) Interest Coverage Ratio (2011 - 2026)
Insmed's (INSM) quarterly Interest Coverage Ratio came in at 7.63 in Q1 2026, up 33.64% year-on-year from 5.71 in Q1 2025, and down 150.54% quarter-over-quarter from 15.11 in Q4 2025.
Insmed (INSM) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Insmed's Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 7.63 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 33.64% year-over-year to 7.63 in Q1 2026; TTM through Mar 2026 was 28.41, a 19.04% decrease from a year earlier, with the FY2025 full-year figure at 0.86, down 9.67% from the prior year.
- Interest Coverage Ratio fell to 7.63 in Q1 2026 per INSM's latest filing, from 15.11 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 15.11 in Q4 2025 and bottomed at 38.08 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 10.14 (2024), against an average of 11.27.
- Across the five-year window, Interest Coverage Ratio tumbled 313.31% in 2022 and surged 217.84% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 7.97 in 2022, then declined by 7.61% to 8.58 in 2023, then soared by 217.84% to 10.11 in 2024, then soared by 49.44% to 15.11 in 2025, then plunged by 150.54% to 7.63 in 2026.
- Per Business Quant, the three latest INSM Interest Coverage Ratio figures stand at 7.63 (Q1 2026), 15.11 (Q4 2025), and 17.96 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -7.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 |
| Dec 31, 2025 | 15.11 |
| Sep 30, 2025 | -17.96 |
| Jun 30, 2025 | -14.73 |
| Mar 31, 2025 | -11.50 |
| Dec 31, 2024 | 10.11 |
| Sep 30, 2024 | -10.14 |
| Jun 30, 2024 | -13.58 |
| Mar 31, 2024 | -6.91 |
| Dec 31, 2023 | -8.58 |
| Sep 30, 2023 | -7.28 |
| Jun 30, 2023 | -11.42 |
| Mar 31, 2023 | -7.41 |
| Dec 31, 2022 | -7.97 |
| Sep 30, 2022 | -38.08 |
| Jun 30, 2022 | -26.31 |
| Mar 31, 2022 | -27.30 |
| Dec 31, 2021 | -3.07 |
| Sep 30, 2021 | -9.21 |
| Jun 30, 2021 | -8.58 |